Skip to content

Abre™ AB9U10080090Recalls & reported problems

Medtronic, Inc. · STENT AB9U10080090 ABRE V01 · Class 3 · Implant

All models of Abre (26)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00643169796171), received between Mar 6, 2025 and Mar 6, 2025 — classified as 1 malfunction.

The most frequently reported specific device problem is “Device Markings/Labelling Problem” (1 report).

3 other recalls cover devices cleared under the same FDA submission (P200026); they may or may not involve this specific model.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 1 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Device Markings/Labelling Problem1
  • Packaging Problem1

Patient problems

  • No Clinical Signs, Symptoms or Conditions1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionMar 6, 2025Device Markings/Labelling Problem; Packaging Problem; Device Markings/Labelling Problem; Packaging Problem

    PHYSICIAN WAS ATTEMPTING TO USE ABRE STENT TO TREAT LEFT MID FIBROUS LESION IN COMMON ILIAC VEIN. IT WAS REPORTED THAT THERE WAS A TEAR IN THE PACKAGING. A NEW DEVICE WAS USED TO COMPLETE THE PROCEDURE. NO PATIENT IMPACT REPORTED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 21534151 ↗

Recalls under the same FDA submission

These recalls involve devices cleared under P200026. One submission often covers many models, so check the product and lot details in each record.

  • Z-1098-2026 · Dec 4, 2025 · Open, Classified
    Abre Venous Self-Expanding Stent System, Model numbers AB9G14120090 AB9G12100090 AB9G14080090 AB9G12080090 AB9U12060090 AB9U14100090 AB9U14080090 AB9U12080090 AB9U14060090 AB9G1410
  • Z-0464-2022 · Nov 19, 2021 · Terminated
    Instructions for Use for all model numbers of the Medtronic Abre Venous Self-Expanding Stent System.
  • Z-1532-2021 · Mar 16, 2021 · Terminated
    Medtronic Abre Venous Self-expanding Sent System, Catalog number REF AB9U16080090 - Product Usage: intended for use in the iliofemoral veins for the treatment of symptomatic venous

Other Stent, iliac vein devices

All Stent, iliac vein devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page